Prolactin and estrogens in multiple sclerosis hormonal imbalance, connection with etiopatogenesis and influence on course of disease
Keywords:
prolactin, estrogens, multiple sclerosisAbstract
Multiple sclerosis (MS) is a chronic inflammatory-demyelinization disease of the central nervous sys-tem which is classified as an autoimmune disorder. Endocrine system dysfunctions, which were widely described in MS patients, can be associated both with the demyelinization process, as well as with treat-ment effects. Strong relationship between endocrine and immune system can be observed there. Prolactin and sex hormones, in particular estrogens, are the groups of hormones which have the immunomodula-tory properties. Their influence on the immunological processes is complex and still not well known. They can probably also play an important role in MS pathogenesis. From the recent studies results it can be concluded that they can influence on the course of the disease and that they can be used as figure thera-peutic agents in MS patients.
Downloads
References
Compston A., Coles A., Multiple sclerosis, Lancet 2002, 359: 1221–1231.
Szczepanik M., Tutaj M, Filipczak-Bryniarska I., Bryniarski K., Eksperymentalne metody leczenia stwardnienia rozsianego – nowe nadzieje, ogromne możliwości, Przeg Lek 2005 , 62(2): 115–118.
Soldan S.S., Retuerto A.I.A., Sicotte N.L., Voskuhl R.R.: Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J. Immunol. 2003, 171: 6267–6274.
Fabis M.J., Scott G.S., Kean R.B., Koprowski H., Craig Hooper D., Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models, Proc Natl Acad Sci U S A 2007 March 27 , 104(13), 5656–5661.
Janiec K., Wajgt A., Kondera-Anasz Z., Effect of immunosupressive cladribine treatment on serum leukocytes system in two-year clinical trial in patients with chronic progressive multiple sclerosis, Med Sci Monit 2001, 7(1): 93–98.
Ciesielska A., Immunosupresyjne właściwości estrogenów, Neurol Neurochir Pol 2003, Suplement: 379–392.
Esquifino A.I., Cano P., Zapata A., Cardinali D.P., Experimental allergic encephalomyelitis in pituitary – grafted lewis rats. J. Neuroinfiammation 2006, 6: 20–23.
Lin W., Bailey S.L., Ho H., Harding H.P., Ron D., Miller S.D., Popko B., The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage, J. Clin Invest 2007, 117 (2), 448–456.
Van den Broek H., Damoiseaux J., Baets M., Hupperts R., The influence of sex hormones on cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis: a review, MultScler. 2005, 11: 349–359.
Duquette P., Hormonal factors in multiple sclerosis, Int MSJ 2001, 9(1): 17–25.
Voskuhl R.R., Gender issues and multiple sclerosis, Curr Neurol Neurosci Rep 2002, 2 (3): 277–286.
Moldovan I.R., Cotleur A.C., Zamor N., Butler R.S., Pelfrey CM., Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens. J. Neuroimmunol. 2008, 193(1-2), 161–169.
Zorgdrager A., De Keyser J.: The premenstrual period and exacerbations in multiple sclerosis, Eur Neurol 2002, 48 (4): 204-206.
Wilson S., Parratt J., O'Riordan J., Swingler R.: Premenstrual worsening of MS symptoms, J. Neurol Sci 2001, 187(1): 336.
Salemi G., Callari G., Gammino M, Battaglieri F., Cammarata E., Cuccia G., i wsp.: The relapse rate of multiple sclerosis changes during pregnancy: a cohort study. Acta Neurol Scand 2004, 110: 23–26.
Vukusic S., Hutchinson M., Hours M., Moreau T., Cortinovis-Tourniaire P., Adeleine P. i wsp., The Pregnancy in Multiple Sclerosis Group, Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of postpartum relapse, Brain 2004, 127: 1353–1360.
Smith R., Studd J.W., A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle, J.R. Soc Med 1992, 85: 612–613.
Zych-Twardowska E., Wajgt A., Blood levels of selected hormones in patients with multiple sclerosis, Med Sci Monit 2001, 7(5): 1005–1012.
Zych-Twardowska E., Wajgt A., Serum prolactin and sex hormone concentrations in patients with multiple sclerosis, Med Sci Monit 1999; 5(2): 216–220.
Chikanza I.C., Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann NY Acad Sci 1999, 876: 119–130.
Harirchaian M.H., Sahraian M.A., Shirani A., Serum prolactin level in patients with multiple sclerosis: A case control study, Med Sci Monit. 2006, 12 (4): 177–180.
Kira J., Harada M., Yamaguchi Y., Shida N., Goto I., Hyperprolactinemia in multiple sclerosis, J. Neurol Sci. 1991, 102: 61–66.
Matera L., Endocrine, paracrine and autocrine actions of prolactin on immune cells, Life Sci 1996, 59: 599–614.
Heesen C, Gold S.M., Bruhn M., Monch A., Schulz KH.: Prolactin stimulation in multiple sclerosis - An indicator of disease subtypes and activity? Endocr Res 2002, 28 (1-2): 9–18.
Dijkstra CD., Polman C.H., Berkenbosch F.: Multiple sclerosis: some possible therapeutic opportunities, Trends. Pharmacol.Sci. 1993, 14: 124–129.
Hubina E., Nagy G.M., Toth B.E., Ivan G., Gorombey Z., Szaboks I., Kovacs L., Goth M.I.: Dexamethasone and adrenocorticotropin suppress prolactin secretion in humans, Endocrine 2002, 18: 215-219.
Linssen W.H., Notermans N.C., Hommes O.R., Rolland R., Amenorrhea after immunosuppresive treatment of multiple sclerosis, Acta Neurol Scand 1987, 76: 204–209.
Grinsted L., Heltberg A., Hagen C, Djursing H., Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis J. Intern Med 1989, 226: 241–244.
Klapps P., Seyfert S., Fischer T., Scherbaum W.A.: Endocrine function in multiple sclerosis, Acta Neurol Scand 1992, 85: 353–357.
T., Lightman S.L.: The neuroendocrine axis in patients with multiple sclerosis. Brain 1997, 120: 1067–76.
Minderhoud JM., Leemhuis JG., Kremer J., Laban E., Smits PML., Sexual disturbances arising from multiple sclerosis, Acta Neurol Scand 1984, 70: 299-306.
Fox H.S., Bond B.L., Parslow T.G., Estrogen regulates the INF-γ promoter, J. Immunol 1991, 146: 4362–4367.
Gulshan S., McCruden A.B., Stimson W.H., Estrogen receptors in macrophages, Scand J. Immunol 1990, 31: 691–697.
Matejuk A., Bakke AC, Hopke C, Dwyer J, Vandenbark AA., Offner H., Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis, J. Neurosci Res 2004, 77: 119–126.
Offner H.: Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis. J. Neurosci Res 2004, 78: 603–624.
Sicotte NL., Liva SM., Klutch R., Pfeiffer P., Bouvier S., Odesa S. i wsp., Treatment of multiple sclerosis with the pregnancy hormone estriol, Ann Neurol 2002, 52: 421–428.
Offner H., Adlard K., Zamora A., Vandenbark AA.: Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis J. Clin Invest 2000, 105: 1465–1467.
Ito A. Bebo BF., Matejuk A., Zamora A., Silverman M. i wsp: Estrogen treatment down-regulates TNF-α production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J. Immunol 2001, 167: 542–552.
Subramanian S., Matejuk A., Zamora A., Vanden-Bark AA., Offner H., Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and into inhibits the recruitment of inflammatory cells into the central nervous system. J. Immunol 2003, 170: 1548–55.
Voskuhl RR., Hormone -based therapies in SM. Int MSJ 2003, 10 (2): 61–66.
Herman MA., Hohol MJ., Olek MJ., Piegelman D., Ascherio A., Oral contraceptives and the incidence of multiple sclerosis. Neurology 2000, 55: 848–854.
Gilmore W., Weiner LP., Correale J., Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects, J. Immunol. 1997, 158: 446–451.
Marzi M., Vigano A., Trabattoni D., Villa ML., Salvaggio A., Clerici E. i wsp., Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy, Clin Exp Immunol 1996, 106 (1): 127–133.
Sayetta RB.: Theories of the ethiology of multiple sclerosis : a critical review, J. Clin Immunol 1986, 21: 55.
Weber F.: Effects of autoreative T cells and cytokines in the pathogenesis of multiple sclerosis, Int MSJ 2001, 9 (1): 29–35.
Peeva E., Grimaldi C., Spatz L., Diamond B., Bromocriptine restores tolerance in estrogen-treated mice. J. Clin Invest 2000, 106: 1373–1379.
Matusik E., Wajgt A., Janowska J., Zahorska-Markiewicz B., Wpływ terapii metyloprednizolonem na stężenia sICAM-1, sVCAM-1 u chorych z postacią postępującoremitującą stwardnienia rozsianego, Neurol Nerochir Poi 2005, 4(supl. 2): 264.
Santizo R., Pelligrino DA. Estrogen leukocyte adhesion in the cerebral circulation of female rats, J. Cereb Blood Flow Metab 1999, 19: 1061–1065.
Al-Omaishi J., Bashir R., Gendelman HE., The cellular immunology of multiple sclerosis, J. Leukoc Biol 1999, 65, 444–452.
Lliev A., Traykov V., Stoykov I., Yakimova K., Estradiol inhibits astrocytic GFAP expression in an animal model of neuroinflammation. Methods Find Exp Clin Pharmacol 2001, 23: 29–35.
Drew PD., Chavis JA., Female sex steroids: effects upon microglial cell activation. Neuroimmunol 2000, 111: 78–85.
Schumacher M., Robel P., Baulieu EE., Development and regeneration of the nervous system: arole of neurosteroids. Dev. Neurosci. 1996, 18 (1-2): 6–21.
Chan JR., Rodriguez-Waitkus PM., Ng BK., Liang P., Glaser M., Progesterone synthesized by Schwann cells during myelin formation regulates neuronal gene expression, Mol Biol Cell 2000, 11 (7): 2283-2295.
Piccinni MP., Giudizi MG, Biagiotti R., Beloni L., Giannarini L., Sampognaro S. i wsp., Progesterone favours the development of human T helper cells producing Th2-type cytokines and promotes both 11-4 production and membrane CD30 expression in established Thl cell clones. J. Immunol 1995, 155: 128–133.
Kim S., Liva S.M., Dalai MA., Verity MA., Voskuhl RR., Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis, Neurology 1999, 52: 1230–1238.
Tomassini V., Onesti E., Mainero C., Giugni E., Paolillo A., Salvetti M. i wsp., Sex hormones modulate brain damage in multiple sclerosis, MRI evidence. J. Neurol Neurosurg Psychiatry 2005, 76: 272–275.
Garcia- Estrada J., Del Rio J.A., Luquin S i wsp. Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury, Brain Res 1993, 628: 271–278.
Palaszynski KM., Loo KK., Ashouri JF., Liu H., Voskuhl RR.,: Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J. Neuroimmunol 2004, 146: 144–52.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2008 Medical Journal of the Rzeszow University
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
